Led Medical (LEDIF) 0.0867 $LEDIF
LED Medical Diagnostics Inc. Reports 2016 First Quarter Results
Marketwire Canada - Fri May 27, 6:00AM CDT
VANCOUVER, BC--(Marketwired - May 27, 2016) - LED Medical Diagnostics Inc. (TSX VENTURE: LMD) (OTCQX: LEDIF) (FRANKFURT: LME) ("LED Medical" or the "Company"
today announced its financial results for the first quarter ended March 31, 2016, reported in United States dollars and in accordance with International Financial Reporting Standards ("IFRS". The Company's results are presented in comparison to the first quarter ended March 31, 2015. All balances are expressed in United States dollars unless otherwise stated.
LMD.VN: 0.110 (+0.005)
LED Medical Diagnostics Retains Bristol Capital as Investor Relations Advisor
Marketwired - Thu May 19, 10:00AM CDT
VANCOUVER, BC--(Marketwired - May 19, 2016) - LED Medical Diagnostics Inc. ("LED" or the "Company" (TSX VENTURE: LMD) (OTCQX: LEDIF) (FRANKFURT: LME) is pleased to announce that it has retained Bristol Capital Ltd. as its investor relations advisor. Bristol has been retained to assist LED Medical in achieving greater visibility amongst current and prospective investors through the dissemination and communication of corporate materials, conference calls and road show activity.
LMD.VN: 0.110 (+0.005)
LED Medical Diagnostics Launches New TUXEDO(TM) Intraoral Sensor
Marketwired - Thu May 12, 6:30AM CDT
New Sensor Delivers High-Definition Imaging Combined With Five Years of Deductible-Free Warranty Coverage
LMD.VN: 0.110 (+0.005)
LED Medical Diagnostics Inc. Reports 2015 Fourth Quarter and Full Year Results
Marketwired - Mon Apr 11, 4:30PM CDT
LED Medical Diagnostics Inc. (TSX VENTURE: LMD) (OTCQX: LEDIF) (FRANKFURT: LME) ("LED Medical" or the "Company" today announced its financial results for the fourth quarter and full year ended December 31, 2015, reported in United States dollars and in accordance with International Financial Reporting Standards ("IFRS". The Company's results are presented in comparison to the fourth quarter and full year ended December 31, 2014. All balances are expressed in United States dollars unless otherwise stated.
LMD.VN: 0.110 (+0.005)
FDA Approves LED Medical's New Tuxedo Digital Intraoral Radiography System
Marketwired - Tue Mar 29, 5:00PM CDT
LED Medical Diagnostics Inc. ("LED" or the "Company" (TSX VENTURE: LMD) (OTCQX: LEDIF) (FRANKFURT: LME) announced that its subsidiary, LED Dental Inc., has now received 510K approval from the FDA for its new Tuxedo(TM) digital intraoral radiography system to be marketed and sold in the United States.
LMD.VN: 0.110 (+0.005)
LED Medical Diagnostics Announces Grant of Stock Options
Marketwired - Fri Feb 05, 4:30PM CST
LED Medical Diagnostics Inc. (TSX VENTURE: LMD) (OTCQX: LEDIF) (FRANKFURT: LME) ("LED" or the "Company" announces the grant of 3,075,000 stock options to directors, officers, employees and consultants of the Company, in accordance with its stock option plan. Each option has an eight year term and is exercisable at CDN$0.18 per share.
LMD.VN: 0.110 (+0.005)
LED Medical Diagnostics Announces Successful Results for Latest Clinical Research Using VELscope(R) Tissue Fluorescence Technology
Marketwired - Tue Jan 26, 8:02AM CST
LED Medical Diagnostics Inc. (TSX VENTURE: LMD) (OTCQX: LEDIF) (FRANKFURT: LME) ("LED" or the "Company" is pleased to announce that the results of a study, titled "Fluorescence Visualization-Guided Surgery for Early-Stage Oral Cancer", have been published in the Journal of the American Medical Association - Otolaryngology - Head and Neck Surgery.
LMD.VN: 0.110 (+0.005)
LED Medical Announces Preliminary Revenue Results for Fiscal 2015
WorldStockWire - Thu Jan 14, 10:00PM CST
LED Medical Diagnostics Inc. (TSX VENTURE: LMD) (OTCQX: LEDIF) (FRANKFURT: LME) ("LED" or the "Company" announced today preliminary unaudited revenue for its fiscal year ended December 31, 2015 of approximately US$12.5 million which represents approximately 40% revenue growth over the prior fiscal year. In addition, the Company had US$2.5 million in customer backlogged orders as of December 31, 2015, due to strong sales volume experienced in late fiscal 2015. These orders are expected to be delivered and installed in early fiscal 2016. Final recognized revenue is subject to completion of the Company's annual audit and will be released with the Company's audited financial statements and related annual report in due course.
LMD.VN: 0.110 (+0.005)
LED Medical Diagnostics Inc. Announces Successful Resolution to FDA Warning Letter
Marketwired - Tue Jan 12, 6:25PM CST
LED Medical Diagnostics ("LED Medical" or "the Company" (TSX VENTURE: LMD)(OTCQX: LEDIF)(FRANKFURT: LME) subsidiary LED Dental is pleased to announce that it has received confirmation from the United States Food and Drug Administration (FDA) that it has adequately addressed the agency's concerns outlined in a Warning Letter sent to the company dated May 12, 2014. This confirmation brings to a conclusion the negotiations between LED Dental and the FDA regarding certain marketing verbiage on the LED Dental website pertaining to the VELscope Vx system. LED Dental completed the requested changes to the website in December 2015 and received notification shortly thereafter that the changes were acceptable.
LMD.VN: 0.110 (+0.005)
LED Medical Diagnostics Inc. Reports 2015 Third Quarter Results
Marketwired - Mon Nov 30, 4:12PM CST
LED Medical Diagnostics Inc. (TSX VENTURE: LMD) (OTCQX: LEDIF) (FRANKFURT: LME) ("LED Medical" or the "Company" today announced its financial results for the third quarter ended September 30, 2015, reported in United States dollars and in accordance with International Financial Reporting Standards ("IFRS". LED Medical achieved 10% annual revenue growth to US$1.8 million in the third quarter of 2015 versus the same period in 2014. The Company's year to date revenue for the nine months ended September 30, 2015 increased by 75% to US$7.5 million over the prior year revenue of US$4.3 million.
LMD.VN: 0.110 (+0.005)
LED Medical Diagnostics Inc. Reports 2016 First Quarter Results
Marketwire Canada - Fri May 27, 6:00AM CDT
VANCOUVER, BC--(Marketwired - May 27, 2016) - LED Medical Diagnostics Inc. (TSX VENTURE: LMD) (OTCQX: LEDIF) (FRANKFURT: LME) ("LED Medical" or the "Company"
today announced its financial results for the first quarter ended March 31, 2016, reported in United States dollars and in accordance with International Financial Reporting Standards ("IFRS". The Company's results are presented in comparison to the first quarter ended March 31, 2015. All balances are expressed in United States dollars unless otherwise stated. LMD.VN: 0.110 (+0.005)
LED Medical Diagnostics Retains Bristol Capital as Investor Relations Advisor
Marketwired - Thu May 19, 10:00AM CDT
VANCOUVER, BC--(Marketwired - May 19, 2016) - LED Medical Diagnostics Inc. ("LED" or the "Company"
(TSX VENTURE: LMD) (OTCQX: LEDIF) (FRANKFURT: LME) is pleased to announce that it has retained Bristol Capital Ltd. as its investor relations advisor. Bristol has been retained to assist LED Medical in achieving greater visibility amongst current and prospective investors through the dissemination and communication of corporate materials, conference calls and road show activity. LMD.VN: 0.110 (+0.005)
LED Medical Diagnostics Launches New TUXEDO(TM) Intraoral Sensor
Marketwired - Thu May 12, 6:30AM CDT
New Sensor Delivers High-Definition Imaging Combined With Five Years of Deductible-Free Warranty Coverage
LMD.VN: 0.110 (+0.005)
LED Medical Diagnostics Inc. Reports 2015 Fourth Quarter and Full Year Results
Marketwired - Mon Apr 11, 4:30PM CDT
LED Medical Diagnostics Inc. (TSX VENTURE: LMD) (OTCQX: LEDIF) (FRANKFURT: LME) ("LED Medical" or the "Company"
today announced its financial results for the fourth quarter and full year ended December 31, 2015, reported in United States dollars and in accordance with International Financial Reporting Standards ("IFRS". The Company's results are presented in comparison to the fourth quarter and full year ended December 31, 2014. All balances are expressed in United States dollars unless otherwise stated. LMD.VN: 0.110 (+0.005)
FDA Approves LED Medical's New Tuxedo Digital Intraoral Radiography System
Marketwired - Tue Mar 29, 5:00PM CDT
LED Medical Diagnostics Inc. ("LED" or the "Company"
(TSX VENTURE: LMD) (OTCQX: LEDIF) (FRANKFURT: LME) announced that its subsidiary, LED Dental Inc., has now received 510K approval from the FDA for its new Tuxedo(TM) digital intraoral radiography system to be marketed and sold in the United States. LMD.VN: 0.110 (+0.005)
LED Medical Diagnostics Announces Grant of Stock Options
Marketwired - Fri Feb 05, 4:30PM CST
LED Medical Diagnostics Inc. (TSX VENTURE: LMD) (OTCQX: LEDIF) (FRANKFURT: LME) ("LED" or the "Company"
announces the grant of 3,075,000 stock options to directors, officers, employees and consultants of the Company, in accordance with its stock option plan. Each option has an eight year term and is exercisable at CDN$0.18 per share. LMD.VN: 0.110 (+0.005)
LED Medical Diagnostics Announces Successful Results for Latest Clinical Research Using VELscope(R) Tissue Fluorescence Technology
Marketwired - Tue Jan 26, 8:02AM CST
LED Medical Diagnostics Inc. (TSX VENTURE: LMD) (OTCQX: LEDIF) (FRANKFURT: LME) ("LED" or the "Company"
is pleased to announce that the results of a study, titled "Fluorescence Visualization-Guided Surgery for Early-Stage Oral Cancer", have been published in the Journal of the American Medical Association - Otolaryngology - Head and Neck Surgery. LMD.VN: 0.110 (+0.005)
LED Medical Announces Preliminary Revenue Results for Fiscal 2015
WorldStockWire - Thu Jan 14, 10:00PM CST
LED Medical Diagnostics Inc. (TSX VENTURE: LMD) (OTCQX: LEDIF) (FRANKFURT: LME) ("LED" or the "Company"
announced today preliminary unaudited revenue for its fiscal year ended December 31, 2015 of approximately US$12.5 million which represents approximately 40% revenue growth over the prior fiscal year. In addition, the Company had US$2.5 million in customer backlogged orders as of December 31, 2015, due to strong sales volume experienced in late fiscal 2015. These orders are expected to be delivered and installed in early fiscal 2016. Final recognized revenue is subject to completion of the Company's annual audit and will be released with the Company's audited financial statements and related annual report in due course. LMD.VN: 0.110 (+0.005)
LED Medical Diagnostics Inc. Announces Successful Resolution to FDA Warning Letter
Marketwired - Tue Jan 12, 6:25PM CST
LED Medical Diagnostics ("LED Medical" or "the Company"
(TSX VENTURE: LMD)(OTCQX: LEDIF)(FRANKFURT: LME) subsidiary LED Dental is pleased to announce that it has received confirmation from the United States Food and Drug Administration (FDA) that it has adequately addressed the agency's concerns outlined in a Warning Letter sent to the company dated May 12, 2014. This confirmation brings to a conclusion the negotiations between LED Dental and the FDA regarding certain marketing verbiage on the LED Dental website pertaining to the VELscope Vx system. LED Dental completed the requested changes to the website in December 2015 and received notification shortly thereafter that the changes were acceptable. LMD.VN: 0.110 (+0.005)
LED Medical Diagnostics Inc. Reports 2015 Third Quarter Results
Marketwired - Mon Nov 30, 4:12PM CST
LED Medical Diagnostics Inc. (TSX VENTURE: LMD) (OTCQX: LEDIF) (FRANKFURT: LME) ("LED Medical" or the "Company"
today announced its financial results for the third quarter ended September 30, 2015, reported in United States dollars and in accordance with International Financial Reporting Standards ("IFRS". LED Medical achieved 10% annual revenue growth to US$1.8 million in the third quarter of 2015 versus the same period in 2014. The Company's year to date revenue for the nine months ended September 30, 2015 increased by 75% to US$7.5 million over the prior year revenue of US$4.3 million. LMD.VN: 0.110 (+0.005)
